StockData
ICLRNasdaqServices-Commercial Physical & Biological Research

ICON PLC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on May 27, 2026
$168.14−2.04 (-1.20%)

Close on Oct 19, 2026

Market cap
$13.01B
P/E (TTM)
300.2
Dividend yield
–

Earnings

Next report expected Oct 21, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Jul 29, 2026After market close$2.06B$0.94$2.56
Q1 FY2026
Ended Mar 31, 2026
Apr 29, 2026Before market open–––
Q3 FY2025
Ended Sep 30, 2025
Oct 22, 2025After market close$2.04B$0.03$3.31
Q2 FY2025
Ended Jun 30, 2025
Jul 23, 2025After market close$2.02B$2.30$3.26
Q1 FY2025
Ended Mar 31, 2025
Apr 30, 2025After market close$2.00B$1.90$3.19
Q4 FY2024
Ended Dec 31, 2024
Feb 19, 2025After market close$2.04B$3.16$3.43
Q3 FY2024
Ended Sep 30, 2024
Oct 23, 2024After market close$2.03B$2.36$3.35
Q2 FY2024
Ended Jun 30, 2024
Jul 24, 2024After market close$2.12B$1.76$3.75
Q1 FY2024
Ended Mar 31, 2024
Apr 24, 2024After market close–––
Q4 FY2023
Ended Dec 31, 2023
Feb 21, 2024After market close–––
Q3 FY2023
Ended Sep 30, 2023
Oct 25, 2023After market close–––

Company guidance

Outlook given with results on Jul 29, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
adjusted diluted earnings per share*non-GAAP2026 full-year$10.00 to $11.00New
revenue2026 full-year$7.85B to $8.15BNew

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements ICON filed with the SEC